Literature DB >> 2424495

Immunochemical analysis of subunit structures of 1,4-dihydropyridine receptors associated with voltage-dependent Ca2+ channels in skeletal, cardiac, and smooth muscles.

A Schmid, J Barhanin, T Coppola, M Borsotto, M Lazdunski.   

Abstract

Previous purification studies of the 1,4-dihydropyridine receptor associated with the calcium channel of rabbit skeletal muscle had shown that it is composed of a large glycoprotein of Mr 140,000-145,000 associated with a smaller component of Mr 32,000-34,000. Specific antisera have now been prepared against the larger component (anti-140 serum) and the smaller one (anti-32 serum). The specificity of these two antisera has been analyzed by immunoblot assays with microsomal preparations of rabbit skeletal muscle. Under disulfide-reducing conditions the anti-140 serum specifically labeled a polypeptide of Mr 140,000 while the anti-32 serum labeled three polypeptides of Mr 32,000, 29,000, and 26,000. Under nonreducing conditions both the anti-140 and the anti-32 sera specifically recognized a single large polypeptide of Mr 170,000. The same type of approach showed that the dihydropyridine receptor in cardiac and smooth muscles had a polypeptide composition similar to that found in skeletal muscle with a large polypeptide of Mr 170,000-176,000 made of two different chains of about Mr 140,000 and 34,000-32,000 associated by disulfide bridges.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424495     DOI: 10.1021/bi00360a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Isolation and characterization of distinct domains of sarcolemma and T-tubules from rat skeletal muscle.

Authors:  P Muñoz; M Rosemblatt; X Testar; M Palacín; A Zorzano
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

2.  Subcellular distribution and isolation of the Ca2+ antagonist receptor associated with the voltage regulated Ca2+ channel from rabbit heart muscle.

Authors:  B S Tuana; B J Murphy; Q Yi
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

3.  Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle.

Authors:  M Takahashi; M J Seagar; J F Jones; B F Reber; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 4.  Reconstitution of channel proteins from excitable cells in planar lipid bilayer membranes.

Authors:  M Montal
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

5.  Monoclonal antibody specific for the transverse tubular membrane of skeletal muscle activates the dihydropyridine-sensitive Ca2+ channel.

Authors:  N N Malouf; R Coronado; D McMahon; G Meissner; G Y Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

6.  Heterogeneity of calcium channels from a purified dihydropyridine receptor preparation.

Authors:  J A Talvenheimo; J F Worley; M T Nelson
Journal:  Biophys J       Date:  1987-11       Impact factor: 4.033

Review 7.  Calcium channels: molecular pharmacology, structure and regulation.

Authors:  M M Hosey; M Lazdunski
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

8.  The T-tubule is a cell-surface target for insulin-regulated recycling of membrane proteins in skeletal muscle.

Authors:  P Muñoz; M Rosemblatt; X Testar; M Palacín; G Thoidis; P F Pilch; A Zorzano
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

9.  The purified Ca2+ antagonist receptor from skeletal muscle: subunit structure, photoaffinity labeling and endogenous protein kinase activity.

Authors:  B S Tuana; B J Murphy; Q Yi
Journal:  Mol Cell Biochem       Date:  1988 Mar-Apr       Impact factor: 3.396

10.  Partial purification of a protein from maize (Zea mays) coleoptile membranes binding the Ca2+-channel antagonist verapamil.

Authors:  H J Harvey; M A Venis; A J Trewavas
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.